Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
Thirty five years ago, India chose to go down two paths, on both of which it remains. The first path...
Read moreDetailsIt started, as many big stories do these days, with a tweet. A blunt social media post by a mid-sized...
Read moreDetailsI t is prudent for officials in high positions to speak with care and caution, for their words carry the...
Read moreDetailsWhen US President Donald Trump’s administration in a new fiat, made the coveted H-1B visa available to foreigners at a...
Read moreDetails